FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024493032> ?p ?o ?g. }

• W2024493032 endingPage "1362" @default.
• W2024493032 startingPage "1356" @default.
• W2024493032 abstract "<h3>Objectives:</h3> To determine the efficacy of subsequent disease modifying antirheumatic drug (DMARD) therapies after initial methotrexate (MTX) failure in patients with recent onset rheumatoid arthritis (RA), treated according to the DAS for 2 years. <h3>Methods:</h3> In groups 1 and 2 of the BeSt study, 244 RA patients were initially treated with MTX 15–25 mg/week. Patients who discontinued MTX because of insufficient clinical response (disease activity score, DAS >2.4) or toxicity were classified as “MTX failures.” In group 1, these patients switched to sulfasalazine (SSA), then leflunomide and finally to MTX + infliximab (IFX). In group 2, “MTX failures” added SSA to MTX, then hydroxychloroquine (HCQ), then prednisone, and eventually switched to MTX + IFX. “MTX successes” were patients who achieved a DAS ⩽2.4 after 2 years while still on MTX monotherapy. Total Sharp/van der Heijde score (TSS) progression from 0–2 years was assessed in “MTX failures” versus “MTX successes.” <h3>Results:</h3> After 2 years, 162/244 patients (66%) had discontinued MTX because of insufficient response or toxicity. Of these, 78% also failed on SSA (adding or switching), 87% subsequently failed on leflunomide (in group 1), and 64% on MTX + SSA + HCQ (in group 2). 34 of 48 patients (71%) in groups 1 and 2 were successfully treated with MTX + IFX. After 2 years, regardless of the “success” on subsequent DMARDs, “ MTX failures” had a median TSS progression of 3 units (mean 9) versus 1 unit (mean 3) in “MTX successes” (p = 0.007). <h3>Conclusion:</h3> After failure on initial MTX, treatment with subsequent conventional DMARDs is unlikely to result in a DAS ⩽2.4 and allows progression of joint damage." @default.
• W2024493032 created "2016-06-24" @default.
• W2024493032 creator A5006079113 @default.
• W2024493032 creator A5015727845 @default.
• W2024493032 creator A5017391629 @default.
• W2024493032 creator A5021075566 @default.
• W2024493032 creator A5052424289 @default.
• W2024493032 creator A5059705239 @default.
• W2024493032 creator A5069122327 @default.
• W2024493032 creator A5075477472 @default.
• W2024493032 creator A5085213730 @default.
• W2024493032 creator A5085647986 @default.
• W2024493032 creator A5085970105 @default.
• W2024493032 date "2007-10-01" @default.
• W2024493032 modified "2023-09-25" @default.
• W2024493032 title "Limited efficacy of conventional DMARDs after initial methotrexate failure in patients with recent onset rheumatoid arthritis treated according to the disease activity score" @default.
• W2024493032 cites W1274762127 @default.
• W2024493032 cites W1596381381 @default.
• W2024493032 cites W1867131794 @default.
• W2024493032 cites W1977466305 @default.
• W2024493032 cites W1988848155 @default.
• W2024493032 cites W2000905503 @default.
• W2024493032 cites W2002240106 @default.
• W2024493032 cites W20155150 @default.
• W2024493032 cites W2046628605 @default.
• W2024493032 cites W2054888624 @default.
• W2024493032 cites W2072677308 @default.
• W2024493032 cites W2073104311 @default.
• W2024493032 cites W2083525176 @default.
• W2024493032 cites W2083673654 @default.
• W2024493032 cites W2095898469 @default.
• W2024493032 cites W2096965824 @default.
• W2024493032 cites W2097564087 @default.
• W2024493032 cites W2101830854 @default.
• W2024493032 cites W2111540856 @default.
• W2024493032 cites W2116843833 @default.
• W2024493032 cites W2120332428 @default.
• W2024493032 cites W2126952749 @default.
• W2024493032 cites W2133837925 @default.
• W2024493032 cites W2134171514 @default.
• W2024493032 cites W2135763952 @default.
• W2024493032 cites W2139063743 @default.
• W2024493032 cites W2142500530 @default.
• W2024493032 cites W2156449368 @default.
• W2024493032 cites W2156996668 @default.
• W2024493032 cites W2157684375 @default.
• W2024493032 cites W2163089977 @default.
• W2024493032 cites W2168419457 @default.
• W2024493032 cites W2265946565 @default.
• W2024493032 cites W2268787646 @default.
• W2024493032 cites W2319957449 @default.
• W2024493032 cites W2331320446 @default.
• W2024493032 cites W2345361184 @default.
• W2024493032 doi "https://doi.org/10.1136/ard.2006.066662" @default.
• W2024493032 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1994290" @default.
• W2024493032 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17293364" @default.
• W2024493032 hasPublicationYear "2007" @default.
• W2024493032 type Work @default.
• W2024493032 sameAs 2024493032 @default.
• W2024493032 citedByCount "89" @default.
• W2024493032 countsByYear W20244930322012 @default.
• W2024493032 countsByYear W20244930322013 @default.
• W2024493032 countsByYear W20244930322014 @default.
• W2024493032 countsByYear W20244930322015 @default.
• W2024493032 countsByYear W20244930322016 @default.
• W2024493032 countsByYear W20244930322017 @default.
• W2024493032 countsByYear W20244930322018 @default.
• W2024493032 countsByYear W20244930322019 @default.
• W2024493032 countsByYear W20244930322020 @default.
• W2024493032 countsByYear W20244930322021 @default.
• W2024493032 countsByYear W20244930322022 @default.
• W2024493032 countsByYear W20244930322023 @default.
• W2024493032 crossrefType "journal-article" @default.
• W2024493032 hasAuthorship W2024493032A5006079113 @default.
• W2024493032 hasAuthorship W2024493032A5015727845 @default.
• W2024493032 hasAuthorship W2024493032A5017391629 @default.
• W2024493032 hasAuthorship W2024493032A5021075566 @default.
• W2024493032 hasAuthorship W2024493032A5052424289 @default.
• W2024493032 hasAuthorship W2024493032A5059705239 @default.
• W2024493032 hasAuthorship W2024493032A5069122327 @default.
• W2024493032 hasAuthorship W2024493032A5075477472 @default.
• W2024493032 hasAuthorship W2024493032A5085213730 @default.
• W2024493032 hasAuthorship W2024493032A5085647986 @default.
• W2024493032 hasAuthorship W2024493032A5085970105 @default.
• W2024493032 hasBestOaLocation W20244930322 @default.
• W2024493032 hasConcept C126322002 @default.
• W2024493032 hasConcept C141071460 @default.
• W2024493032 hasConcept C198451711 @default.
• W2024493032 hasConcept C2775905006 @default.
• W2024493032 hasConcept C2777077863 @default.
• W2024493032 hasConcept C2777138892 @default.
• W2024493032 hasConcept C2777575956 @default.
• W2024493032 hasConcept C2778397455 @default.
• W2024493032 hasConcept C2778720950 @default.
• W2024493032 hasConcept C2779123688 @default.
• W2024493032 hasConcept C2779134260 @default.
• W2024493032 hasConcept C2779383735 @default.
• W2024493032 hasConcept C2780479503 @default.

• next